Sign In
Buy CORT
$72.65
+1.45 (+2.04%)
At Close: Jun 03, 2026
Investor Alert: Robbins LLP Informs Investors of the Corcept Therapeutics Inc. Class Action Lawsuit
08:13pm, Friday, 20'th Feb 2026
SAN DIEGO--(BUSINESS WIRE)---- $CORT #Health--Robbins LLP informs stockholders that a class action was filed on behalf of all investors who purchased or otherwise acquired Corcept Therapeutics Incorpo
Corcept Therapeutics: The Bad News Is Priced In; The Ovarian Cancer Upside Is Not
07:30am, Friday, 20'th Feb 2026
Corcept Therapeutics is upgraded to Buy after a patent loss and FDA setback, with focus shifting to relacorilant in oncology. Despite Korlym's imminent generic erosion, CORT's $524M liquidity and cost
Corcept Provides Update on Patent Dispute with Teva Pharmaceuticals
04:00pm, Thursday, 19'th Feb 2026
REDWOOD CITY, Calif.--(BUSINESS WIRE)--Corcept Therapeutics Incorporated (NASDAQ: CORT), a commercial-stage company engaged in the discovery and development of medications to treat severe endocrinolog
Corcept Therapeutics Stock Plunges As Court Clears Teva Generic
11:48am, Thursday, 19'th Feb 2026
Corcept had argued that Teva's label for its generic version of Korlym, a drug used to treat Cushing's syndrome, would induce doctors to follow patented dosing methods involving mifepristone and stron
Aberdeen Group plc Sells 19,501 Shares of Corcept Therapeutics Incorporated $CORT
04:32am, Wednesday, 18'th Feb 2026
Aberdeen Group plc trimmed its holdings in shares of Corcept Therapeutics Incorporated (NASDAQ: CORT) by 7.0% during the third quarter, according to its most recent 13F filing with the Securities and
REDWOOD CITY, Calif.--(BUSINESS WIRE)--Corcept Therapeutics Incorporated (NASDAQ: CORT) today announced it will report fourth quarter and full-year 2025 financial results and provide a corporate updat
NEW YORK, Feb. 17, 2026 (GLOBE NEWSWIRE) -- Do you, or did you, own shares of Corcept Therapeutics Incorporated (NASDAQ: CORT)? Did you lose money in your investment in Corcept Therapeutics Incorporat
CORT ALERT: Ongoing Investigation Into Corcept Therapeutics Incorporated - Contact Levi & Korsinsky
12:39am, Monday, 16'th Feb 2026
New York, New York--(Newsfile Corp. - February 16, 2026) - Levi & Korsinsky notifies investors that it has commenced an investigation into Corcept Therapeutics Incorporated ("Corcept Therapeutics Inco
INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Corcept Therapeutics Incorporated - CORT
06:56pm, Thursday, 12'th Feb 2026
NEW YORK, Feb. 12, 2026 /PRNewswire/ -- Pomerantz LLP is investigating claims on behalf of investors of Corcept Therapeutics Incorporated ("Corcept" or the "Company") (NASDAQ: CORT). Such investors
NEW YORK, Feb. 12, 2026 (GLOBE NEWSWIRE) -- Do you, or did you, own shares of Corcept Therapeutics Incorporated (NASDAQ: CORT)? Did you lose money in your investment in Corcept Therapeutics Incorporat
NEW YORK, Feb. 10, 2026 (GLOBE NEWSWIRE) -- Bernstein Liebhard LLP: Do you, or did you, own shares of Corcept Therapeutics Incorporated (NASDAQ: CORT)? Did you lose money in your investment in Corcept
14,712 Shares in Corcept Therapeutics Incorporated $CORT Bought by Versor Investments LP
04:00am, Tuesday, 10'th Feb 2026
Versor Investments LP bought a new position in Corcept Therapeutics Incorporated (NASDAQ: CORT) in the undefined quarter, according to the company in its most recent Form 13F filing with the Securitie
CORT Investors Have Opportunity to Join Corcept Therapeutics Incorporated Fraud Investigation with the Schall Law Firm
10:58am, Monday, 09'th Feb 2026
LOS ANGELES, Feb. 09, 2026 (GLOBE NEWSWIRE) -- The Schall Law Firm, a national shareholder rights litigation firm, announces that it is investigating claims on behalf of investors of Corcept Therapeut
SAN FRANCISCO, Feb. 9, 2026 /PRNewswire/ -- The latest adverse development for Corcept Therapeutics (NASDAQ: CORT) concerning its proposed treatment of patients with hypercortisolism (also known as Cu
Corcept Therapeutics Incorporated Investigated on Behalf of Investors - Contact the DJS Law Group to Discuss Your Rights - CORT
04:54am, Monday, 09'th Feb 2026
LOS ANGELES, Feb. 9, 2026 /PRNewswire/ -- The DJS Law Group announces that it is investigating claims on behalf of investors of Corcept Therapeutics Incorporated ("Corcept" or "the Company") (NASDAQ
